Regeneron Pharmaceuticals
REGN
REGN
576 hedge funds and large institutions have $26.3B invested in Regeneron Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 92 funds opening new positions, 220 increasing their positions, 180 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
4% more funds holding
Funds holding: 553 → 576 (+23)
10% less call options, than puts
Call options by funds: $732M | Put options by funds: $814M
10% less capital invested
Capital invested by funds: $29.4B → $26.3B (-$3.08B)
Holders
576
Holding in Top 10
12
Calls
$732M
Puts
$814M
Top Buyers
| 1 | +$208M | |
| 2 | +$194M | |
| 3 | +$162M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$94.6M |
| 5 |
Renaissance Technologies
New York
|
+$92M |
Top Sellers
| 1 | -$481M | |
| 2 | -$466M | |
| 3 | -$257M | |
| 4 |
Goldman Sachs
New York
|
-$214M |
| 5 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$91.1M |